| 2026-05-06 |
详情>>
业绩披露：
2026年一季报每股收益10.93丹麦克朗,归母净利润485.57亿丹麦克朗,同比去年增长67.24%
|
| 2026-05-05 |
详情>>
股本变动：
变动后总股本443285.10万股
|
| 2026-02-04 |
复牌提示：
2026-02-03 11:35:29 停牌，复牌日期 2026-02-03 11:56:03
|
| 2026-02-04 |
详情>>
业绩披露：
2025年年报每股收益23.06丹麦克朗,归母净利润1024.34亿丹麦克朗,同比去年增长1.43%
|
| 2026-02-04 |
详情>>
业绩披露：
2023年年报每股收益18.67丹麦克朗,归母净利润836.83亿丹麦克朗,同比去年增长50.71%
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益17.00丹麦克朗,归母净利润755.43亿丹麦克朗,同比去年增长3.83%
|
| 2025-08-06 |
详情>>
业绩披露：
2025年中报每股收益12.50丹麦克朗,归母净利润555.37亿丹麦克朗,同比去年增长22.17%
|
| 2025-08-06 |
财报披露：
美东时间 2025-08-06 盘前发布财报
|
| 2025-05-07 |
详情>>
业绩披露：
2025年一季报每股收益6.54丹麦克朗,归母净利润290.34亿丹麦克朗,同比去年增长14.28%
|
| 2025-02-27 |
股东大会：
将于2025-03-27召开股东大会
会议内容 ▼▲
- 1.The Board of Directors’ oral report onthe Company’s activities in the pastfinancial year;
2.Presentation and adoption of the auditedAnnual Report 2024;
3.Resolutlon to distrlibute the profit accordingto the adopted Annual Report 2024;
4.Presentation of and advisory vote on theRemuneration Report 2024;
5.Remuneratlion: 5.1 Approval of the remuneration of the Board of Directors for 2024; 5.2 Approval of the remuneration level of the Board of Directors for 2025;
6.Electlon of members to the Boardof Directors: 6.1 Election of chair; 6.2 Election of vice chalr; 6.3 Elect’on of other members to the Board of Directors;
7.Appointment of auditor;
8.Proposals from the Board of Directors and/or shareholders: 8.1 Authorisation to the Board of Directors to allow the Company to repurchase own shares; 8.2 Authorisation to the Board of Directors to increase the Company’s share capital; 8.3 Proposal from the shareholder Kritiskce Aktionaerer on construction contracts;
9.Any other business.
|
| 2025-02-05 |
详情>>
业绩披露：
2024年年报每股收益22.67丹麦克朗,归母净利润1009.88亿丹麦克朗,同比去年增长20.68%
|
| 2025-02-05 |
详情>>
业绩披露：
2022年年报每股收益12.26丹麦克朗,归母净利润555.25亿丹麦克朗,同比去年增长16.27%
|
| 2024-11-06 |
详情>>
业绩披露：
2024年三季报(累计)每股收益16.33丹麦克朗,归母净利润727.58亿丹麦克朗,同比去年增长17.88%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益10.20丹麦克朗,归母净利润454.57亿丹麦克朗,同比去年增长15.84%
|
| 2024-05-02 |
详情>>
业绩披露：
2024年一季报每股收益5.70丹麦克朗,归母净利润254.07亿丹麦克朗,同比去年增长28.23%
|
| 2023-09-20 |
详情>>
拆分方案：
每1.0000股拆分成2.0000股
|
| 2023-02-22 |
股东大会：
将于2023-03-23召开股东大会
会议内容 ▼▲
- 1.The Board of Director's oral report on the Company's activities in the past fianacial year.
2.Presentation and adoption of the audited Annual Report 2022.
3.Resolution to distribute the profit according to the adopted Annual Report 2022.
4.Presentation of and advisory vote on the Remuneration Report 2022.
5.Approval of the remuneration of the Board of Directors.
6.Election of members to the Board of Directors.
7.Appointment of auditor.
8.Proposal from the Board of Directors and/or shareholders.
9.Any other business.
|
| 2022-02-22 |
股东大会：
将于2022-03-24召开股东大会
会议内容 ▼▲
- Financial year 2021 and board remuneration
1.Approval of the Company’s statutory Annual Report 2021 and distribution of profits according to the statutory Annual Report 2020.
2.The final dividend for 2021 of DKK 6.90 for each Novo Nordisk A or B share of DKK 0.20. The total dividend for 2021 of DKK 10.40 includes both the interim dividend of DKK 3.50 for each Novo Nordisk A and B share of DKK 0.20 which was paid in August 2021 and the final dividend of DKK 6.90 for each Novo Nordisk A and B share of DKK 0.20 to be paid in March 2022.
3.The Remuneration Report 2021 was approved (advisory vote).
4.The actual remuneration of the Board of Directors for 2021 and the remuneration level for 2022 were approved.
Elections
5.Re-election of Helge Lund as chair of the Board of Directors.
6.Election of Henrik Poulsen as vice chair of the Board of Directors.
7.Re-election of Jeppe Christiansen, Laurence Debroux, Andreas Fibig, Sylvie Gregoire, Kasim Kutay and Martin Mackay as members of the Board of Directors.
8.Election of Christina Law as new member of the Board of Directors.
9.Re-appointment of Deloitte Statsautoriseret Revisionspartnerselskab as the Company’s auditor.
Shares and capital
10.Reduction of the Company’s B share capital by cancellation of part of the Company’s own holding of B shares. The Company’s B share capital is reduced by DKK 6,000,000 from DKK 354,512,800 to DKK 348,512,800. The Company’s A share capital of DKK 107,487,200 remains unchanged, whereby the Company’s share capital will amount to DKK 456,000,000.
11.Authorisation to the Board of Directors until the Annual General Meeting 2023 to allow the Company to repurchase own shares of up to 10% of the share capital subject to a holding limit of 10% of the share capital.
12.Extension of the authorisation to the Board of Directors to increase the Company's share capital for a period of one year until 24 March 2024 up to nominally DKK 45,600,000.
Other
13.Amendments to the Remuneration Policy regarding payment of contribution to social security taxes imposed by foreign authorities outside the EU and regarding severance payment.
14.Amendment to the Articles of Association regarding removal of age limit on candidates standing for election to the Board of Directors.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-02-23 |
股东大会：
将于2021-03-25召开股东大会
会议内容 ▼▲
- 1.The Board of Directors' oral report on the Company's activities in the past financial year
2.Presentation and adoption of the statutory Annual Report 2020
3.Resolution to distribute the profit according to the adopted statutory Annual Report 2020
4.Presentation and advisory vote on the remuneration report 2020
5.Approval of the remuneration of the board of directors
5.1.Approval of the remuneration of the board of directors 2020
5.2.Approval of the remuneration level for 2021
6.Election of members to the Board of Directors
6.1.Election of chairman
6.2.Election of vice chairman
6.3.Election of other members to the Board of Directors
7.Appointment of auditor
8.Proposals from the Board of Directors and/or shareholders:
8.1.Reduction of the Company's B share capital by nominally DKK 8,000,000 by cancetlation of B shares
8.2.Authorisation to the Board of Directors to allow the Company to repurchase own shares
8.3.Authorisation to the Board of Directors to increase the Company's shares capital
8.4.Indemnification of the board of directors and executive management
8.5.Amendments to the remueration policy
8.6.Amendments of the articles of association
8.7Proposals from shareholders
9.Any other business
|
| 2020-02-21 |
股东大会：
将于2020-03-26召开股东大会
会议内容 ▼▲
- 1.The Board of Directors' oral report on the Company's activities in the past financial year
2.Presentation and adoption of the statutory Annual Report 2019
3.Remuneration：
3.1.Presentation of the Remuneration Report 2019
3.2.Approval of (a) the remuneration of the Board of Directors for 2019 and (b) the remuneration level for 2019
3.3.Adoption of Remuneration Policy
3.4.Amendment of the Articles of Association
4.Resolution to distribute the profit according to the adopted statutory Annual Report 2019
5.Election of members to the Board of Directors:
5.1.Election of chairman
5.2.Election of vice chairman
5.3.Election of other members to the Board of Directors
6.Appointment of auditor
7.Proposals from the Board of Directors:
7.1.Reduction of the Company's B share capital by nominally DKK 10,000,000 by cancellation of B shares
7.2.Authorisation to the Board of Directors to allow the Company to repurchase own shares
7.3.Authorisation to the Board of Directors to increase the Company's share capital
7.4.Approval of donation to the World Diabetes Foundation
8.Proposal from the shareholders:
8.1.Information on the ratio between executive and employee remuneration
9.Any other business
|
| 2019-08-09 |
除权日：
美东时间 2019-08-16 每股派息0.32美元
|
| 2019-02-22 |
股东大会：
将于2019-03-21召开股东大会
会议内容 ▼▲
- 1.The Board of Directors' oral report on the Company's activities in the past financial year
2.Presentation and adoption of the statutory Annual Report 2018
3.Approval of the remuneration of the Board of Directors for 2018 and the remuneration level for 2019
3.1.Approval of actual remuneration for 2018
3.2.Approval of remuneration level for 2019
4.Resolution to distribute the profit according to the adopted statutory Annual Report 2018
5.Election of members to the Board of Directors, induding chairman and vice chairman
5.1.Election of chairman
5.2.Election of vice chairman
5.3.Election of other members to the Board of Directors
6.Appointment of auditor
7.Proposals from the Board of Directors:
7.1.Reduction of the Company's B share capital by nominally DKK 10,000,000 by cancetlation of B shares
7.2.Authorisation to the Board of Directors to allow the Company to repurchase own shares
7.3.Authorisation to the Board of Directors to increase the Company's shares capital
7.4.Approval of changes to the Remuneration Pnnciples
8.Proposal from the shareholders:
8.1.Reduction of price of insulin and other products if return on equity exceeds 7%.
9.Any other business
|
| 2018-08-21 |
除权日：
美东时间 2018-08-17 每股派息0.33美元
|
| 2018-02-23 |
股东大会：
将于2018-03-22召开股东大会
会议内容 ▼▲
- 1.The Board of Directors' oral report on the Company's activities in the past financial year.
2.Presentation and adoption of the statutory Annual Report 2017.
3.Approval of the remuneration of the Board of Directors for 2017 and the remuneration level for 2018.
3.1.Approval of actual remuneration for 2017.
3.2.Approval of actual remuneration for 2018.
4.Resolution to distribute the profit according to the adopted statutory Annual Report 2017.
5.Election of members to the Board of Directors, induding chairman and vice chairman.
5.1. Election of chairman.
5.2. Election of vice chairman.
5.3. Election of other members to the Board of Directors.
6.Appointment of auditor
7.Proposals from the Board of Directors:
7.1. Reduction of the Company's 8 share capital by nominally DKK 10,000,000 by cancetlation of B shares.
7.2. Authorisation to the Board of Directors to allow the Company to repurchase own shares.
7.3. Approval of changes to the Remuneration Pnnciples.
8.Any other business
|
| 2017-08-09 |
除权日：
美东时间 2017-08-17 每股派息0.34美元
|
| 2017-02-26 |
除权日：
美东时间 2017-03-23 每股派息0.48美元
|
| 2017-02-24 |
股东大会：
将于2017-03-23召开股东大会
会议内容 ▼▲
- 1. The Board of Directors' oral report on the Company's activities in the past financial year.
2. Presentation and adoption of the statutory Annual Report 2016
3. Approval of the remuneration of the Board of Directors for 2016 and the remuneration level for 2017.
3.1. Approval of actual remuneration for 2016.
3.2. Approval of actual remuneration for 2017.
4. Resolution to distribute the profit according to the adopted statutory Annual Report 2016.
5. Election of members to the Board of Directors, induding chairman and vice chairman.
5.1. Election of chairman.
5.2. Election of vice chairman.
5.3. Election of other members to the Board of Directors.
6. Appointment of auditor
7. Proposals from the Board of Directors:
7.1. Reduction of the Company's 8 share capital by nominally DKK 10,000,000 by cancetlation of B shares.
7.2. Authorisation to the Board of Directors to allow the Company to repurchase own shares.
7.3. Approval of changes to the Remuneration Pnnciples.
8. Proposals from shareholders:
8.1 Free parking for the shareholders in connection with the informal Shareholders' Meeting.
8.2 The buffet after the informal Shareholders' Meeting is served as set table catering.
9. Any other business
|
| 2016-08-08 |
除权日：
美东时间 2016-08-11 每股派息0.33美元
|
| 2016-03-24 |
除权日：
美东时间 2016-03-18 每股派息0.70美元
|
| 2016-02-24 |
股东大会：
将于2016-03-18召开股东大会
会议内容 ▼▲
- 1. The Board of Directors’ oral report on the Company’s activities in the past financial year.
2. Presentation and adoption of the audited Annual Report 2015.
3. Approval of the remuneration of the Board of Directors for 2015 and the remuneration level for 2016.
4. Resolution to distribute the profit according to the adopted Annual Report 2015.
5. Election of members to the Board of Directors, including chairman and vice chairman.
6. Appointment of auditor.
7. Proposals from the Board of Directors:
Reduction of the Company’s B share capital by nominally DKK 10,000,000 by cancellation of B shares.
Amendments to the Articles of Assosiation; abolishment of bearer shares.
Authorisation of the Board of Directors to allow the Company to repurchase own shares.
Amendment to the Articles of Association
Adoption of revised Remuneration Principles.
8. Any other business.
|